Note revised IND for Stage 2 of 002 is seperate discussion to DMOAD and therefore likely timing.
I'm no concerned about FDA feedback on 008 results rather see it as blue sky to potential mega blockbuster durable pain and function results from 002. Treating doctors and patients will simply frontrun the FDA, EMA and TGA. But NOT giving up on China either.
Note revised IND for Stage 2 of 002 is seperate discussion to...
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
23.5¢ |
Change
-0.010(4.08%) |
Mkt cap ! $82.20M | |||
| Open | High | Low | Value | Volume |
| 26.0¢ | 26.0¢ | 23.0¢ | $317.0K | 1.319M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 49998 | 23.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 24.0¢ | 16000 | 2 |
View Market Depth
| Last trade - 16.10pm 06/05/2024 (20 minute delay) ? |
|
|||||
|
Last
23.5¢ |
Change
-0.010 ( 6.00 %) |
||||
| Open | High | Low | Volume | ||
| 25.0¢ | 26.0¢ | 23.0¢ | 531376 | ||
| Last updated 15.58pm 06/05/2024 ? | |||||
| PAR (ASX) Chart |